Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on May 9, 2025
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
GlobeNewswire
·
May 9, 2025
REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA Securities …
Best 5 Tribal Loans Direct Lender Guaranteed Approval For Bad Credit with No Credit Check - Payday Ventures
GlobeNewswire
·
May 9, 2025
HOUSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Payday Ventures, a leading provider of online payday loans, owns multiple providers offering tribal loans direct lender guaranteed approval with no credit check, helping Americans with urgent financial needs get …
Spectral Medical Announces First Quarter and Provides Corporate Update
GlobeNewswire
·
May 9, 2025
Tigris Trial Enrollment completed Topline results expected to be released in August 2025 Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Spectral Medical …
Escuela de Alergia de Hong Kong 2025 de la EAACI: un hito en la educación mundial sobre alergias
GlobeNewswire
·
May 9, 2025
ZÚRICH, May 09, 2025 (GLOBE NEWSWIRE) -- La Academia Europea de Alergia e Inmunología Clínica (EAACI, por sus siglas en inglés), en colaboración con el Instituto de Alergia de Hong Kong (HKIA), se enorgullece de anunciar la inauguración de la Escuela de …
בית הספר לאלרגיה EAACI הונג קונג 2025: ציון דרך בטיפול החדשני העולמי באלרגיה
GlobeNewswire
·
May 9, 2025
ציריך, May 09, 2025 (GLOBE NEWSWIRE) -- האקדמיה האירופית לאלרגיה ואימונולוגיה קלינית (EAACI), בשותפות עם המכון לאלרגיה של הונג קונג (HKIA), גאה להכריז על בית הספר לאלרגיה של EAACI בהונג קונג. ציון דרך משמעותי זה יתרחש בהונג קונג - עיר העולם של אסיה - מרכז …
Sekolah Alergi EAACI Hong Kong 2025: Tonggak Sejarah dalam Pendidikan Alergi Global
GlobeNewswire
·
May 9, 2025
ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinis Eropa (European Academy of Allergy and Clinical Immunology, EAACI), melalui kemitraan dengan Institut Alergi Hong Kong (Hong Kong Institute of Allergy, HKIA), dengan bangga …
2025年度EAACI香港アレルギースクール (EAACI Hong Kong Allergy School 2025)：世界のアレルギー教育におけるランドマーク
GlobeNewswire
·
May 9, 2025
チューリッヒ発, May 09, 2025 (GLOBE NEWSWIRE) -- 欧州アレルギー・臨床免疫学会 (European Academy of Allergy …
EAACI 홍콩 알레르기 스쿨 2025, 글로벌 알레르기 교육의 랜드마크로 시선 모아
GlobeNewswire
·
May 9, 2025
취리히, May 09, 2025 (GLOBE NEWSWIRE) -- 유럽 알레르기 임상 면역학회(EAACI)가 홍콩 알레르기 연구소(HKIA)와 협력하여 제1회 EAACI 홍콩 알레르기 스쿨 (EAACI Hong Kong Allergy School)을 개최하게 된다고 발표했다. 이 중요한 이정표는 동양과 서양이 만나고, 혁신과 전통이 어우러지며, 글로벌 마인드가 모이게 되는 역동적인 허브인 아시아의 세계 도시 홍콩에서 진행될 예정이다. “동양과 서양의 …
EAACI Hong Kong Allergy School 2025: Mercu Tanda dalam Pendidikan Alergi Global
GlobeNewswire
·
May 9, 2025
ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy …
EAACI Hong Kong Allergy School 2025: Ein Meilenstein in der globalen Allergieaufklärung
GlobeNewswire
·
May 9, 2025
ZÜRICH, May 09, 2025 (GLOBE NEWSWIRE) -- Die European Academy of Allergy …
EAACI Hong Kong Allergy School 2025: Um Marco na Educação Global sobre Alergias
GlobeNewswire
·
May 9, 2025
ZURIQUE, May 09, 2025 (GLOBE NEWSWIRE) -- A Academia Europeia de Alergia e Imunologia Clínica (EAACI), em parceria com o Instituto de Alergia de Hong Kong (HKIA), tem a alegria de anunciar a primeira edição da EAACI Hong Kong Allergy School. Este …
École d’allergologie de l’EAACI à Hong Kong 2025 : un modèle pour l’enseignement mondial de l’allergologie
GlobeNewswire
·
May 9, 2025
ZURICH, 09 mai 2025 (GLOBE NEWSWIRE) -- L’Académie européenne d’allergologie et d’immunologie clinique (The European Academy of Allergy …
2025 年 EAACI 香港过敏学校：全球过敏教育的里程碑
GlobeNewswire
·
May 9, 2025
苏黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 欧洲过敏和临床免疫学学会（European Academy of Allergy …
EAACI 香港過敏學校 2025：全球過敏教育的里程碑
GlobeNewswire
·
May 9, 2025
蘇黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 歐洲過敏及臨床免疫學會 (EAACI) 與香港過敏科醫學會 (HKIA) 攜手合作，隆重宣布首屆 EAACI 香港過敏學校開幕。 這項重要的里程碑活動將於香港這個充滿活力的亞洲國際都會展開，東方與西方在此交匯，創新與傳統碰撞，全球思潮匯聚一堂。 2025 年過敏學校以「東方遇見西方」為主題，朝着推動過敏及臨床免疫學跨洲合作邁出了大膽的一步。 …
EAACI Hong Kong Allergy School 2025: ความสำเร็จครั้งสำคัญด้านการศึกษาโรคภูมิแพ้ระดับโลก
GlobeNewswire
·
May 9, 2025
ซูริก, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy …
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
GlobeNewswire
·
May 9, 2025
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 28th Annual …
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 9, 2025
Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 development candidate nomination and IND filing …
Aya Gold & Silver Reports April Production as Zgounder Ramp Up Gains Momentum
GlobeNewswire
·
May 9, 2025
MONTREAL, May 09, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to report continued operational progress at its Zgounder Silver Mine, driven by a strong mine ramp up, exceptional mill …
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …